Skip to main content

GENEVA CAPITAL MANAGEMENT LLC

Position in CRL — Charles River Laboratories International, Inc.

CIK 1009232 MILWAUKEE, WI

Position in CRL

as of Jun 30, 2026 · filed Aug 6, 2026
Position Value
$2,534,151
+$474,156 QoQ
Shares Held
11,174
-6.4% QoQ
Ownership
0.023%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#180
of 564 holders
Holding Since
Mar 2022
18 quarters on record
Voting authority Sole 80% Shared 0% None 20%

Common Shares in CRL Over Time

Shares Held

Position Value (USD)

Position in Diagnostics & Research

Healthcare · as of Jun 30, 2026

GENEVA CAPITAL MANAGEMENT LLC holds $26,085,063 across 4 Diagnostics & Research names. CRL ranks #2 (9.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
2 CRL
Charles River Laboratories International, Inc.
This page
11,174 $2,534,151

All Filings in CRL

Export CSV
18 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,534,151 11,174
2026-03-31 $2,059,995 11,942
2025-12-31 $2,424,878 12,156
2025-09-30 $1,986,572 12,697
2025-06-30 $1,982,352 13,065
2025-03-31 $1,926,204 12,797
2024-12-31 $2,361,033 12,790
2024-09-30 $2,918,306 14,816
2024-06-30 $3,147,038 15,234
2024-03-31 $4,475,551 16,518
2023-12-31 $3,847,173 16,274
2023-09-30 $3,478,252 17,748
2023-06-30 $3,866,286 18,389
2023-03-31 $3,921,967 19,433
2022-12-31 $4,368,894 20,050
2022-09-30 $3,933,440 19,987
2022-06-30 $4,744,997 22,176
2022-03-31 $6,384,213 22,482